Lonza - PBMCs

Appointments

XORTX Therapeutics Appoints Mika Grasso as Co-CEO

Mika Grasso

XORTX Therapeutics Appoints Mika Grasso as Co-CEO

Dr. Luisa Salter-Cid

Dr. Luisa Salter-Cid

Harbour BioMed Appoints Dr. Luisa Salter-Cid as Scientific Advisor

Hubert C. Chen

Hubert C. Chen

Viking Therapeutics Appoints Hubert C. Chen, M.D., as Chief Medical Officer

Evotec Appoints Rui Wang as Head of Global In Silico and AI to Strengthen Data-Driven Drug Discovery

Rui Wang

Evotec Appoints Rui Wang as Head of Global In Silico and AI to Strengthen Data-Driven Drug Discovery

GBI Biomanufacturing Appoints Chandra Kelley as Chief Business Officer to Accelerate Commercial Growth

Chandra Kelley

GBI Biomanufacturing Appoints Chandra Kelley as Chief Business Officer to Accelerate Commercial Growth

Immunic Appoints Erik Lundgren as Chief Executive Officer to Lead Late-Stage Development and Commercialization Efforts

Erik Lundgren

Immunic Appoints Erik Lundgren as Chief Executive Officer to Lead Late-Stage Development and Commercialization Efforts

Vistagen Appoints Angel S. Angelov as Chief Medical Officer to Advance Clinical Development Strategy

Angel S. Angelov

Vistagen Appoints Angel S. Angelov as Chief Medical Officer to Advance Clinical Development Strategy

ATB Therapeutics Appoints Mark Throsby as CEO to Drive Clinical Development and Strategic Growth

Mark Throsby

ATB Therapeutics Appoints Mark Throsby as CEO to Drive Clinical Development and Strategic Growth

OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer to Strengthen Financial and Capital Markets Strategy

Anthony Kim

OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer to Strengthen Financial and Capital Markets Strategy